SPI — Spire Healthcare Cashflow Statement
0.000.00%
Last trade - 00:00
- £994.17m
- £2.20bn
- £1.36bn
- 49
- 46
- 90
- 69
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 9.6 | -231 | -1.9 | 3.9 | 34.6 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 83.7 | 297 | 77.2 | 94.9 | 92.9 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 16.8 | -0.3 | 11.4 | -15.1 | -15.6 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 202 | 160 | 184 | 182 | 216 |
Capital Expenditures | -60.6 | -46.6 | -69.3 | -87.7 | -84.4 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 12 | 0.3 | 21 | -7.6 | -72.8 |
Acquisition of Business | |||||
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -48.6 | -46.3 | -48.3 | -95.3 | -157 |
Financing Cash Flow Items | -75.5 | -84.5 | -80 | -97.6 | -90.6 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -110 | -97.9 | -39.2 | -215 | -82.9 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 43.1 | 15.5 | 96.3 | -128 | -24.6 |